4.4 Review

Vitamin D and Cardiovascular Prevention

期刊

CARDIOVASCULAR THERAPEUTICS
卷 28, 期 4, 页码 e5-e12

出版社

WILEY-HINDAWI
DOI: 10.1111/j.1755-5922.2010.00192.x

关键词

Cardiovascular; Prevention; Treatment; Vitamin D

资金

  1. British Heart Foundation
  2. Diabetes UK
  3. NHS Education, Scotland
  4. Chief Scientist Office, Scottish Government
  5. Chest Heart and Stroke Scotland
  6. Heart Research UK
  7. ME Society

向作者/读者索取更多资源

Vitamin D has been known to medical science for almost a century. Yet, it is only in the last 15 years that we have realized that the biological effects of vitamin D extend far beyond the control of calcium metabolism. Recent observational evidence suggests strong links between low vitamin D levels and a range of cardiovascular conditions, including stroke, myocardial infarction, hypertension, and diabetes. Interventional studies are beginning to explore whether vitamin D supplementation can modify vascular health and prevent cardiovascular disease. This article reviews the physiology and function of vitamin D, examines the current observational and intervention data in cardiovascular disease, and discusses future research and current practice recommendations.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Geriatrics & Gerontology

Effect of Angiotensin System Inhibitors on Physical Performance in Older People - A Systematic Review and Meta-Analysis

Lorna Caulfield, Philip Heslop, Katherine E. Walesby, Deepa Sumukadas, Avan A. Sayer, Miles D. Witham

Summary: The current evidence does not support the use of ACE inhibitors or angiotensin receptor blockers as a single intervention to improve physical performance in older people, based on a systematic review and meta-analysis of randomized controlled trials.

JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2021)

Article Geriatrics & Gerontology

Prediction of Postoperative Outcomes Following Hip Fracture Surgery: Independent Validation and Recalibration of the Nottingham Hip Fracture Score

William J. Doherty, Thomas A. Stubbs, Andrew Chaplin, Mike R. Reed, Avan A. Sayer, Miles D. Witham, Antony K. Sorial

Summary: The study assessed the Nottingham Hip Fracture Score (NHFS) for prediction of mortality, physical function, length of stay, and postoperative complications, finding that NHFS performed consistently well in predicting functional outcomes, moderately in predicting mortality, but less well in predicting length of stay and complications.

JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2021)

Editorial Material Geriatrics & Gerontology

Pandemic research for older people: doing it better next time

Miles D. Witham, Adam L. Gordon, Emily J. Henderson, Rowan H. Harwood

AGE AND AGEING (2021)

Article Urology & Nephrology

A Randomized, Controlled Trial of the Effect of Allopurinol on Left Ventricular Mass Index in Hemodialysis Patients

Elaine Rutherford, Sheila Ireland, Kenneth Mangion, Graham A. Stewart, Mark S. MacGregor, Giles Roditi, Rosemary Woodward, Stephen J. Gandy, J. Graeme Houston, Alan G. Jardine, Petra Rauchhaus, Miles D. Witham, Patrick B. Mark, Allan D. Struthers

Summary: In hemodialysis patients, 12 months of treatment with allopurinol did not regress LVMI. Allopurinol also showed no significant effects on blood pressure, flow-mediated dilation, augmentation indices, or pulse wave velocity.

KIDNEY INTERNATIONAL REPORTS (2021)

Review Health Care Sciences & Services

Why trials lose participants: A multitrial investigation of participants perspectives using the theoretical domains framework

Rumana Newlands, Eilidh Duncan, Justin Presseau, Shaun Treweek, Louisa Lawrie, Peter Bower, Jim Elliott, Jill Francis, Graeme MacLennan, Margaret Ogden, Mary Wells, Miles D. Witham, Bridget Young, Katie Gillies

Summary: This study is the first to explore trial participants' accounts of trial retention informed by behavioral science. The findings will serve as a guiding framework when designing trials to limit barriers and enhance enablers of retention within clinical trials.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2021)

Editorial Material Medicine, General & Internal

Vitamin D supplementation and testing in the UK: costly but ineffective?

Mark J. Bolland, Alison Avenell, Karen Smith, Miles D. Witham, Andrew Grey

BMJ-BRITISH MEDICAL JOURNAL (2021)

Article Surgery

The ViKTORIES trial: A randomized, double-blind, placebo-controlled trial of vitamin K supplementation to improve vascular health in kidney transplant recipients

Jennifer S. Lees, Alastair J. Rankin, Keith A. Gillis, Luke Y. Zhu, Kenneth Mangion, Elaine Rutherford, Giles H. Roditi, Miles D. Witham, Donna Chantler, Maurizio Panarelli, Alan G. Jardine, Patrick B. Mark

Summary: In this study, vitamin K supplementation did not reduce vascular stiffness or calcification in KTR over 1 year. Improving vascular health in KTR is likely to require a multifaceted approach.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

Article Medicine, General & Internal

Multimorbidity and mortality in an older, rural black South African population cohort with high prevalence of HIV findings from the HAALSI Study

Alisha N. Wade, Collin F. Payne, Lisa Berkman, Angela Chang, F. Xavier Gomez-Olive, Chodziwadziwa Kabudula, Kathleen Kahn, Joshua A. Salomon, Stephen Tollman, Miles Witham, Justine Davies

Summary: This study investigated the relationship between multimorbidity and mortality in an older, rural black South African population, finding that multimorbidity was associated with greater risk of death. HIV multimorbidity in men also showed an increased risk of death compared to non-HIV multimorbidity. Adjusting for frailty slightly attenuated the associations between multimorbidity and mortality risk in women, while slightly increasing the associations between HIV multimorbidity and mortality risk.

BMJ OPEN (2021)

Review Rehabilitation

Increasing physical activity levels in care homes for older people: a quantitative scoping review of intervention studies to guide future research

Gavin Wylie, Thilo Kroll, Miles D. Witham, Jacqui Morris

Summary: This scoping review examined interventions to increase physical activity levels in older care home residents. The results showed that current interventions mainly focused on individual resident level factors, with little consideration for broader social and environmental aspects. The interventions were not fully described and lacked a clear theoretical foundation. Future interventions should address contextual care home factors and provide clear descriptions according to intervention description guidelines.

DISABILITY AND REHABILITATION (2023)

Review Geriatrics & Gerontology

Repurposing Drugs for Diabetes Mellitus as Potential Pharmacological Treatments for Sarcopenia - A Narrative Review

Miles D. D. Witham, Antoneta Granic, Ewan Pearson, Sian M. M. Robinson, Avan A. A. Sayer

Summary: Sarcopenia, the age-related loss of muscle strength and mass, has common mechanisms with accelerated ageing seen in diabetes mellitus. Drugs used to treat type 2 diabetes mellitus may have relevance to the prevention and treatment of sarcopenia. Cellular and animal models suggest potential beneficial effects of diabetes drugs on skeletal muscle function, particularly metformin and SGLT2 inhibitors. Intervention studies are needed to investigate the balance of benefit and risk in older individuals with sarcopenia.

DRUGS & AGING (2023)

Article Geriatrics & Gerontology

Using pre-fracture mobility to augment prediction of post-operative outcomes in hip fracture

Thomas A. Stubbs, William J. Doherty, Andrew Chaplin, Sarah Langford, Mike R. Reed, Avan A. Sayer, Miles D. Witham, Antony K. Sorial

Summary: This study assessed the ability of pre-fracture mobility to predict post-operative outcomes in hip fracture patients. Patients with worse mobility had higher mortality, longer length of hospital stay, higher likelihood of living in a care home, and higher likelihood of complications. Including mobility assessment in risk scores can improve casemix adjustment and prognostication following hip fracture.

EUROPEAN GERIATRIC MEDICINE (2023)

Letter Cell Biology

Ageing Research Translation: a new era for UK geroscience

Miles D. Witham, Rachel Cooper, Kelly A. Bowden A. Davies, Sandra Ortega-Martorell, Claire E. Stewart, Avan A. Sayer

NATURE AGING (2022)

Article Medicine, General & Internal

MET-PREVENT: metformin to improve physical performance in older people with sarcopenia and physical prefrailty/frailty - protocol for a double-blind, randomised controlled proof-of-concept trial

Katherine J. Rennie, Miles Witham, Penny Bradley, Andrew Clegg, Stephen Connolly, Helen C. Hancock, Shaun Hiu, Leanne Marsay, Claire McDonald, Laura Robertson, Laura Simms, Alison J. Steel, Claire J. Steves, Bryony Storey, James Wason, Nina Wilson, Thomas von Zglinicki, Avan A. P. Sayer

Summary: This trial aims to investigate whether metformin can improve physical performance in older people with sarcopenia and physical frailty. Participants will receive oral treatment for 4 months and measurements will be taken at the end of the follow-up period. The results will be shared with relevant teams and the scientific community.

BMJ OPEN (2022)

Article Geriatrics & Gerontology

The assessment of sarcopenia and the frailty phenotype in the outpatient care of older people: implementation and typical values obtained from the Newcastle SarcScreen project

R. M. Dodds, P. Heslop, J. Jaffar, K. Davies, J. M. Noble, F. E. Shaw, M. D. Witham, A. A. Sayer

Summary: This study successfully implemented the Newcastle SarcScreen as part of outpatient care for older people. The assessment revealed a high prevalence of probable sarcopenia and the frailty phenotype in all age groups.

EUROPEAN GERIATRIC MEDICINE (2022)

Article Geriatrics & Gerontology

Associations between frailty, physical performance, and renal biomarkers in older people with advanced chronic kidney disease

George Smith, Alison Avenell, Margaret M. Band, Geeta Hampson, Edmund J. Lamb, Roberta C. Littleford, Paul McNamee, Roy L. Soiza, Deepa Sumukadas, Miles D. Witham

Summary: Our study found that biochemical markers associated with chronic kidney disease did not consistently correlate with baseline physical performance or changes in physical performance over time in older patients. Targeting improvements in renal biochemistry may not be an effective way to improve physical function and frailty in this population.

EUROPEAN GERIATRIC MEDICINE (2021)

暂无数据